Haleon Boosts US Sales via GLP-1 Placement Strategy
Consumer health company Haleon has increased US sales by marketing products to counter side effects of popular weight-loss drugs. By placing items in dedicated store displays alongside traditional aisles, the maker of Advil and TUMS achieved notable sales lifts.
Insights:
Consumer health maker Haleon has lifted sales 24% per store in the United States by placing digestive aids next to weight-loss drugs. The strategy capitalizes on soaring demand for GLP-1 treatments that treat obesity.
